Medtronic, a global leader in healthcare technology, announced that it has entered into an agreement with Retia Medical, an innovative digital health company that develops advanced hemodynamic solutions, to distribute the Argos™ cardiac output monitor. The Argos™ monitor provides healthcare professionals with accurate hemodynamic data to support the treatment of high-risk surgical and critically ill patients.

医疗技术领域的全球领导者美敦力公司宣布，已与开发先进血液动力学解决方案的创新数字健康公司Retia Medical达成协议，将分销Argos™心输出量监测仪。Argos™监测仪为医疗专业人员提供精确的血液动力学数据，以支持高风险手术及危重患者的治疗。

The Argos™ monitor is now available in the U.S. exclusively from Medtronic. Financial terms of the agreement were not disclosed..

Argos™ 监护仪现在在美国独家由美敦力公司提供。协议的财务条款未披露。

In the operating room (OR) and critical care units, circulatory shock, often manifested as hypotension, is a primary cause of complications and requires intervention within minutes to prevent damage to vital organs. Hemodynamic monitoring detects important changes in a patient’s hemodynamic status, enabling clinicians to intervene earlier ensuring sufficient oxygen delivery and preserving end organ function..

在手术室 (OR) 和重症监护病房中，循环休克（常表现为低血压）是并发症的主要原因，需要在几分钟内进行干预以防止对重要器官的损害。血流动力学监测可检测患者血流动力学状态的重要变化，使临床医生能够及早干预，确保足够的氧气输送并维持终末器官功能。

“Studies have shown that patients had 1 to 2-day shorter stays in the ICU when preemptive hemodynamic intervention was used,”

“研究表明，当使用抢先的血液动力学干预时，患者在重症监护室的住院时间缩短了1到2天。”

said Blake Tatum, U.S. commercial vice president of the Acute Care & Monitoring business, which is part of the Medical Surgical portfolio at Medtronic. 'The Argos™ cardiac output monitor complements our INVOS™ cerebral oximetry technology to help provide clinicians with comprehensive insights into a patient’s status in both the operating room and intensive care unit.

美敦力外科医疗组合中急症护理与监测业务的美国商业副总裁布莱克·塔图姆说道：“Argos™ 心输出量监测仪补充了我们的 INVOS™ 脑血氧饱和度技术，有助于为临床医生提供在手术室和重症监护室中患者状态的全面洞察。”

By integrating this technology into our Acute Care & Monitoring portfolio, we are advancing our commitment to delivering actionable insights that enable clinicians to personalize care and improve outcomes for critically ill patients.”.

通过将这项技术整合到我们的急性护理和监测产品组合中，我们正在推进我们提供可操作见解的承诺，使临床医生能够个性化护理并改善重症患者的治疗效果。

The Argos™ cardiac output monitor offers an advanced algorithm called Multi-Beat Analysis™ (MBA™), developed at the Massachusetts Institute of Technology (MIT) and Michigan State University. Unlike other monitors that analyze only one beat at a time, the MBA™ algorithm analyzes multiple heartbeats from the blood pressure signal to model a patient’s vascular resistance directly.

Argos™ 心输出量监测仪提供了一种名为多拍分析™（MBA™）的先进算法，该算法由麻省理工学院（MIT）和密歇根州立大学开发。与其他仅一次分析一个心跳的监测仪不同，MBA™ 算法通过血压信号分析多个心跳，以直接模拟患者的血管阻力。

It provides accurate hemodynamic data on ten comprehensive parameters even during changes in vasomotor tone, low cardiac output, and arrhythmia..

即使在血管张力变化、低心输出量和心律失常的情况下，它也能提供关于十个综合参数的精确血流动力学数据。

“Medtronic is the ideal partner for Retia Medical as we expand the reach of the Argos™ cardiac output monitor,” said Marc Zemel, chief executive officer of Retia Medical. “Their robust portfolio, strong customer relationships, and leadership in advancing acute care and monitoring technologies uniquely position them to deliver the benefits of our innovative solution to clinicians and patients in the U.S.

“美敦力是Retia Medical扩大Argos™心输出量监测仪覆盖范围的理想合作伙伴，”Retia Medical首席执行官Marc Zemel表示。“他们强大的产品组合、牢固的客户关系以及在推进急症护理和监测技术方面的领导地位，使他们能够将我们创新解决方案的优势带给美国的临床医生和患者。”

We are excited to partner with Medtronic to set a new standard in hemodynamic monitoring.”.

我们很高兴与美敦力合作，为血流动力学监测树立新的标准。

The Argos™ cardiac output monitor leverages the patient’s existing arterial line using a single reusable cable to connect the monitor to a radial blood pressure transducer. The monitor requires no calibration, features an intuitive multi-touch screen interface, and can be fully operational in minutes.

Argos™ 心输出量监测仪利用患者现有的动脉导管，通过一根可重复使用的电缆将监测仪与桡动脉血压传感器连接起来。该监测仪无需校准，配有直观的多点触控屏幕界面，几分钟内便可全面投入运行。

Training can be completed in less than five minutes. In addition, there is no need for costly disposable accessories to connect. For more information about the Argos™ cardiac output monitor visit medtronic.com/argos..

培训可以在不到五分钟内完成。此外，无需使用昂贵的一次性配件进行连接。有关 Argos™ 心输出量监测仪的更多信息，请访问 medtronic.com/argos。

About Retia Medical

关于Retia Medical

Headquartered in White Plains, NY, Retia Medical Systems, Inc. is a venture-backed developer and provider of advanced algorithms including AI-based approaches for patient monitoring and management. Retia’s mission is to provide accurate data and insights to aid surveillance, diagnosis and management of high-risk surgical and critically ill patients to improve outcomes.

总部位于纽约州白平原的 Retia Medical Systems, Inc. 是一家由风险投资支持的先进算法开发和供应商，包括基于人工智能的患者监测和管理方法。Retia 的使命是提供准确的数据和见解，以帮助对高危手术患者和重症患者进行监测、诊断和管理，从而改善患者预后。

Retia Medical’s Argos™ Monitor, with its Multi-Beat Analysis (MBA®) algorithm, provides consistently accurate hemodynamic measurements for critically ill adult patients, enabling clinicians to make more informed, data-driven decisions to improve end-organ function. Additionally, the Argos™ system is unique in its class by not requiring costly disposables to monitor each patient.

Retia Medical的Argos™监护仪，凭借其多拍分析（MBA®）算法，为危重成年患者提供始终准确的血流动力学测量，帮助临床医生做出更明智、数据驱动的决策以改善终末器官功能。此外，Argos™系统在其同类产品中独树一帜，无需使用昂贵的一次性耗材即可监测每位患者。

The Argos™ uses a single cable connection and takes less than 1 minute to start monitoring. Learn more at .

Argos™ 使用单根电缆连接，启动监测时间不到 1 分钟。请访问 了解更多信息。

About Medtronic

美敦力公司简介

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries.

大胆思考。更果敢的行动。我们是美敦力。美敦力公司总部位于爱尔兰戈尔韦，是全球领先的医疗技术公司，通过寻找并发现解决方案，勇敢地应对人类面临的最严峻的健康问题。我们的使命——减轻病痛、恢复健康、延长生命——将遍布150多个国家的95,000多名充满热情的员工团结在一起。

Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day.

我们的技术和疗法治疗70种健康状况，包括心脏设备、手术机器人、胰岛素泵、手术工具、患者监测系统等。凭借我们多样化的知识、无尽的好奇心和帮助所有需要帮助的人的愿望，我们提供了创新技术，每秒、每小时、每一天都在改变两个人的生活。

Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit .

随着我们推动以洞察力为导向的护理、以人为本的体验以及为我们的世界带来更好的结果，期待我们做得更多。在我们所做的每一件事中，我们都在创造非凡。欲了解有关美敦力的更多信息，请访问。